|
|
Volumn 176, Issue 3, 1997, Pages 748-751
|
|
Editorial: Nosocomial multidrug-resistant tuberculosis - Global spread of the third epidemic
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMYCOBACTERIAL AGENT;
BCG VACCINE;
ISONIAZID;
RIFAMPICIN;
BCG VACCINATION;
CLINICAL TRIAL;
DRUG EFFICACY;
EDITORIAL;
EPIDEMIC;
HEALTH CARE PERSONNEL;
HOSPITAL INFECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
OCCUPATIONAL HAZARD;
PRIORITY JOURNAL;
TUBERCULOSIS;
CROSS INFECTION;
DISEASE TRANSMISSION;
DRUG EFFECT;
HEALTH;
NOTE;
CROSS INFECTION;
DISEASE OUTBREAKS;
HUMANS;
MYCOBACTERIUM TUBERCULOSIS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
WORLD HEALTH;
|
|
EID: 0031227901
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1086/514099 Document Type: Editorial |
|
Times cited : (22)
|
|
References (45)
|
